Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes.
Venous thromboembolism and adverse pregnancy outcomes are potential complications of pregnancy. Numerous studies have evaluated both the risk factors for and the prevention and management of these outcomes in pregnant patients. This consensus group was convened to provide concise recommendations, based on the currently available literature, regarding the use of antithrombotic therapy in pregnant patients at risk for venous thromboembolic events and adverse pregnancy outcomes.
Duhl
Adam J
AJ
Department of Obstetrics and Gynecology, Mercy Hospital of Pittsburgh, Pittsburgh, PA, USA.
Paidas
Michael J
MJ
Ural
Serdar H
SH
Branch
Ware
W
Casele
Holly
H
Cox-Gill
Joan
J
Hamersley
Sheri Lynn
SL
Hyers
Thomas M
TM
Katz
Vern
V
Kuhlmann
Randall
R
Nutescu
Edith A
EA
Thorp
James A
JA
Zehnder
James L
JL
D000328:Adult; D000765:Anesthesia, Conduction; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000990:Antithrombin III / Q000032:analysis / Q000627:therapeutic use; D000991:Antithrombins / Q000032:analysis; D002585:Cesarean Section; D036861:Delivery, Obstetric; D005260:Female; D005333:Fetus / Q000187:drug effects; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage; D006801:Humans; D009765:Obesity / Q000453:epidemiology / Q000503:physiopathology; D016017:Odds Ratio; D049590:Postpartum Period; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control / Q000628:therapy*; D011256:Pregnancy Outcome; D018570:Risk Assessment; D012307:Risk Factors; D013921:Thrombocytopenia / Q000139:chemically induced / Q000628:therapy; D015912:Thrombolytic Therapy; D019851:Thrombophilia; D054556:Venous Thromboembolism / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control / Q000628:therapy*; D014859:Warfarin / Q000009:adverse effects
D000925:Anticoagulants; D000991:Antithrombins; D006495:Heparin, Low-Molecular-Weight; D014859:Warfarin; D000990:Antithrombin III; D006493:Heparin